Condition: Apathy · Schizophrenia · Schizophrenia; Psychosis · Sponsor: Louisiana State University Health Sciences Center Shreveport
This study is looking to determine if Lumateperone improves motivation in patients with schizophrenia or schizoaffective disorders who show high levels of apathy as judged by AES-C-Apathy (Apathy Evaluation Scale - Clinician - Apathy) assessment and to examine a possible correlation between improvement in apathy scores and changes in elements of the PANSS (Positive and Negative Syndrome Scale) due to treatment with Lumateperone.
This description comes directly from the study's public registry record.
Shawn McNeil, MD · 318-675-7065 · shawn.mcneil@lsuhs.edu
Stephanie Saunders, MA, CCRC · 318-675-7065 · stephanie.saunders@lsuhs.edu
Always discuss trial participation with your own doctor first.
| LSU Health Shreveport | Shreveport, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06482554